October 15, 2013

Consulting and broker agency FHS Unternehmensberatung, based in Stuttgart, Germany, and CDMO Recipharm, based in Stockholm, Sweden, have entered into a collaboration. FHS Unternehmensberatung will sell and market Recipharm’s development services, including formulation development, analytical development, manufacture of clinical trial material and stability studies to customers in Austria, Germany and Switzerland.

“I am very excited about this collaboration,” said Torkel Gren, Sales Director, Recipharm Pharmaceutical Development. “FHS Unternehmensberatung has, through its owner Fritz H. Speck, an excellent knowledge of the contract development business and a very valuable network in German speaking countries. I am convinced that this will help us to reach out to new customers.”

“I am deeply impressed by the capabilities, the excellent experience and the staff's extraordinary team spirit at Recipharm PD,” said Fritz Speck, owner of FHS Unternehmensberatung. “To me it seems quite clear, that clients in the German-speaking market could benefit a lot from the attractive opportunities and multilingual experience at Recipharm PD. I look forward to a successful and pleasant cooperation with the team.”

Recipharm AB, +46 8 602 52 00, info@recipharm.com, www.recipharm.com.

FHS Unternehmensberatung, +49 7127 94824 80, info@fhs-benefit.de,

www.fhs-benefit.de.

October 15, 2013

Built with Metro Publisher™